Immunogenetic analysis suggests different pathogenesis for obese and lean African-Americans with diabetic ketoacidosis

Diabetes Care

Volumn 22, Issue 9, 1999, Pages 1517-1523

  Umpierrez, Guillermo E ^a   Woo, Wayne ^b   Hagopian, William A ^b   Isaacs, Scott D ^b   Palmer, Jerry P ^b   Gaur, Lakshmi K ^b   Nepom, Gerald T ^b   Clark, W Scott ^b   Mixon, Peggy S ^b   Kitabchi, Abbas E ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXYBUTYRIC ACID; ACETOACETIC ACID; AUTOANTIBODY; BICARBONATE; C PEPTIDE; DNA; GLUCAGON; GLUCOSE; GLUTAMATE DECARBOXYLASE; HLA ANTIGEN; INSULIN; INSULIN ANTIBODY; PANCREAS ISLET CELL ANTIBODY; PHOSPHOTYROSINE;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC KETOACIDOSIS; DISEASE COURSE; FEMALE; GENE; GENOTYPE; HUMAN; HYPERGLYCEMIA; IMMUNOFLUORESCENCE; IMMUNOGENETICS; IMMUNOPRECIPITATION; INSULIN RELEASE; LEAN BODY WEIGHT; MAJOR CLINICAL STUDY; MALE; NEGRO; OBESITY; PANCREAS ISLET BETA CELL; POLYMERASE CHAIN REACTION; RADIOIMMUNOASSAY; SCINTILLATION COUNTING;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; ALLELES; AUTOANTIBODIES; C-PEPTIDE; DIABETES MELLITUS; DIABETIC KETOACIDOSIS; FEMALE; GENOTYPE; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; IMMUNOGENETICS; INSULIN; MALE; OBESITY;

EID: 0032870333     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.22.9.1517     Document Type: Article

References (46)

1. Umpierrez GE, Kelly JP, Navarrete JE, Casals MMC, Kitabchi AE: Hyperglycemic crises in urban African-American patients. Arch Int Med 157:669-675, 1997
2. Winter WE, McLaren NK, Riley WJ, Clarke DW, Kappy MS, Spillar RP: Maturity-onset diabetes of youth in black Americans. N Engl J Med 316:285-291, 1987
3. Banerji MA, Chaiken RL, Huey H, Tuomi T, Norm AJ, Mackay IR, Rowley MJ, Zimmet PZ, Lebovitz HE: GAD antibody negative NIDDM in adult black subjects with diabetic ketoacidosis and increased frequency of human leukocyte antigen DR3 and DR4: Flatbush diabetes. Diabetes 43:741-745, 1994
4. Pinhas-Haniel O, Dolan LM, Zeitlers PS: Diabetic ketoacidosis among obese African-American adolescents with NIDDM. Diabetes Care 20:484-486, 1997
5. Umpierrez GE, Casals MMC, Gebhart SSP, Mixon PS, Clark WS, Phillips LS: Diabetic ketoacidosis in obese African-Americans. Diabetes 44:790-795, 1995
6. Banerji MA, Chaiken RL, Lebovitz HE: Prolongation of near-normoglycemic remission in black NIDDM subjects with chronic low-dose sulfonylurea treatment. Diabetes 44:466-470, 1995
7. Umpierrez GE, Steen MT, Clark WS: Sulfonylurea treatment prevents recurrence of hyperglycemia in obese African-American patients with history of hyperglycemic crises. Diabetes Care 20:479-483, 1996
8. American Diabetes Association: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20:1183-1197, 1997
9. Umpierrez GE, Khajavi M, Kitabchi AE: Diabetic ketoacidosis and hyperglycemic hyperosmolar nonketotic syndrome. Am J Med Sci 311:225-233, 1996
10. Greenbaum CJ, Palmer JP, Nagataki S, Yamaguchi Y, Molenaar JL, VanBeers WA, MacLaren NK, Lernmark A: Improved specificity of ICA assays in the Fourth International Immunology of Diabetes Serum Exchange Workshop. Diabetes 41:1570-1574, 1992
11. Hegewald M, Schoenfeld S, McCulloch D, Greenbaum C, Klaff L, Palmer JP: Increased specificity and sensitivity of insulin antibody measurements in autoimmune thyroid disease and type I diabetes. J Immunol Method 154:61-68, 1992
12. Hagopian WA, Sanjeevi CB, Kockum I, Landin O, Olsson M, Karben AE, Sundkvist G, Dahlquist G, Palmer J, Lernmark A: Glutamate decarboxylase-, insulin-, and islet cell-antibodies and HLA typing to detect diabetes in a general population-based study of Swedish children. J Clin Invest 95:1505-1511, 1995
13. Verge CF, Stenger D, Bonifacio E, Colman PG, Pilcher C, Bingley PJ, Eisenbarth GS: Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop. Diabetes 47:1857-1866, 1998
14. Rabin DU, Pleasic SM, Palmer-Cracker R, Shapiro JA: Cloning and expression of IDDM-specific human autoantigens. Diabetes 41:183-186, 1992
15. Rabin D, Pleasic S, Shapiro J, Yoo-Warren H, Oles J, Hicks JM, Goldstein DE, Rae PM: Islet antigen 512 is a diabetes-specific islet autoantigen related to protein tyrosine phosphatases. J Immunol 152:3183-3188, 1994
16. Verge CF, Gianani R, Kawasahi E, Yu L, Pietropaolo M, Jackson RA, Chase HP, Eisenbarth GS: Prediction of type 1 diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes 45:926-933, 1996
17. Lan MS, Lu J, Goto Y, Notkins AL: Molecular cloning and identification of a receptor-type protein tyrosine phosphatase, IA-2, from human insulinoma. DNA Cell Biol 13:505-514, 1994
18. Bugawan TL, Erlich HA: Rapid typing of HLA-DQB1 DNA polymorphism using nonradioactive oligonucleotide probes and amplified DNA. Immunogenetics 33: 163-170, 1991
19. Leech NJ, Kitabchi AE, Gaur LK, Hagopian WA, Hansen T, Burghen GA, Palmer JP, Nepom GT: Genetic and immunological markers of insulin dependent diabetes in black Americans. Autoimmunity 22:27-32, 1995
20. Nepon GT: Immunogenetics and IDDM. Diabetes Rev 1:93-103, 1993
21. Bjork E, Berne C, Kampe O, Wibell L, Oskarsson P, Karlsson FA: Diazoxide treatmerit at onset preserves residual insulin secretion in adults with autoimmune diabetes. Diabetes 45:1427-1430, 1996
22. Kobayashi T, Nakanishi K, Murase T, Kosaka K: Small doses of subcutaneous insulin as a strategy for preventing slowly progressive β-cell failure in islet cell antibody-positive patients with clinical features of NIDDM. Diabetes 45:622-626, 1996
23. Wagner R, Genovese S, Bosi E: Slow metabolic deterioration towards diabetes in islet cell antibody positive patients with autoimmune polyendocrine disease. Diabetologia 37:365-71, 1994
24. Grosz A, Halmos T, P'ancz'el P, Kautzky L, Jakab A: Clinical picture of slow-evolving insulin-dependent diabetes mellitus ("1 1/2"). Orv Hetil 134:1631-1634, 1993
25. Hayek A, Beattie GM, Cirulli V, Lopez AD, Ricordi C, Rubin JS: Growth factor/matrix-induced proliferation of human adult β-cells. Diabetes 44:1458-1460, 1995
26. Scharfmann R, Czernichow P: Differentiation and growth of pancreatic beta cells. Diabetes Metab 22:223-228, 1996
27. Unger RH, Grundy S: Hyperglycemia as an inducer as well as a consequence of impaired islet cell function and insulin resistance: implications for the management of diabetes. Diabetologia 28:119-121, 1985
28. Gjessing HJ, Reinhold B, Pedersen O: The effect of chronic hyperglycemia on the islet cell-β-cell responsiveness in newly diagnosed type 2 diabetes. Diabetic Med 9:601-604, 1992
29. Leahy JL: Natural history of β-cell dysfunction in NIDDM. Diabetes Can 13:992-1010, 1990
30. DeFronzo RA, Bonadonna RC, Ferrannini E: Pathogenesis of NIDDM: A balance overview. Diabetes Care 15:318-368, 1992
31. Bottazzo GF, Florin-Christensen A, Doniach D: Islet cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiency. Lancet ii: 1279-1283, 1974
32. Palmer JR Asplin CM, Clemons P: Insulin autoantibodies in insulin-dependent diabetes before insulin treatment. Science 222:1337-1338, 1983
33. Hagopian WA, Karlsen AE, Gottsater A, Landin O, Olsson M, Grubin CE, Sundkvist G, Petersen JS, Boel E, Dyrberg T, Lernmark A: Quantitative assay using recombinant human islet glutamic acid decarboxylase (GAD65) shows that 65K autoantibodies positivity at onset predicts diabetes type. J Clin Invest 91:368-374, 1003
34. Christie M, Landin-Olsson M, Sundkvist G, Dahlquist G, Lernmark A: Autoantibodies to a 64,000-Mr islet cell protein in Swedish children with newly diagnosed type 1 (insulin-dependent) diabetes. Diabetologia 31:597-602, 1988
35. Molback AC, Christau B, Marner B, Borch-Johnsen K, Nerup J: Incidence of insulin-dependent diabetes mellitus in age groups over 30 years in Denmark Diabetic Med 11:650-655, 1994
36. Vandewalle C, Falorni A, Svanholm S, Lernmark A, Pipeleers D, Gorus F: High diagnostic sensitivity of glutamate decarboxylase autoantibodies in insulin-dependent diabetes mellitus with clinical onset between age 20 and 40 years: the Belgian Diabetes Registry J Clin Endocrinol Metab 80:846-851, 1995
37. Marshall MO, Hxyer PE, Petersen JS, Hejnaes KR, Genovese S, Dyrberg T, Botazzo GF: Contribution of glutamate decarboxylase antibodies to the reactivity of islet cell cytoplasmic antibodies. J Autoimmun 7: 497-508, 1994
38. Bonifacio E, Lampasona Y Genovese S, Ferrari M, Bosi E: Identification of protein tyrosine phosphatase-like IA2 (islet cell antigen 512) as the insulin-dependent diabetes-related 37/40K autoantigen and a target of islet-cell antibodies. J Immunol 155:5419-5426, 1995
39. Niskanen I, Karjalainen J, Sarlund H, Siitonen O, Uusitupa M: Five-year follow-up of islet cell antibodies in type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 34:402-408, 1991
40. Kobayashi T: Subtype of insulin-dependent diabetes mellitus (IDDM) in Japan: slowly-progressive IDDM: the clinical characteristics and pathogenesis of the syndrome. Diabetes Res Clin Pract 24:595-599, 1994
41. Nakanishi K, Kobayashi T, Sugimoto T, Murase T, Itoh T, Kosaka K: Predictive value of insulin autoantibodies for further progression of beta cell dysfunction in non-insulin-dependent diabetes. Diabetes Res 9:105-109, 1988
42. Tuomi T, Groop LC, Zimmet PZ, Rowley MJ, Knowles W, Mackay IR: Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with non-insulin-dependent onset of disease. Diabetes 42:359-362, 1993
43. Zimmet P, Rowley M, Mackay I: The ethnic distribution of autoantibodies to glutamic acid decarboxylase: presence and levels in insulin-dependent diabetes mellitus in Europid and Asian subjects. J Diabetes Complications 7 :1-7, 1993
44. Zimmet PZ, Shaten BJ, Kuller LH, Rowley MJ, Knowles WJ, Mackay IR: Antibodies to glutamic acid decarboxylase and diabetes mellitus in the multiple risk factor intervention trial. Am J Epidemiol 140:683-690, 1994
45. Al-Attas OS: Correlates of insulin autoantibodies with beta cell function at the time of diagnosis of diabetes mellitus. Am J Med Sci 310:138-142, 1995
46. Vannasaeng S, Humphrey ARC, Mackay IR: Differing frequency of autoantibodies to glutamic acid decarboxylase among Koreans, Thais and Australians with diabetes mellitus. Clin Immunol Immunopathol 74: 202-206, 1995